First is the size of the treatment area
9 Research gaps and future priorities 9.1 Reproductive-oriented RCTs: shifting from metabolic surrogates to hard endpoints To date, most GLP-1RA trials in PCOS have been designed around metabolic efficacy (weight change and insulin-resistance/glycaemic indices) as the primary outcomes, with reproductive outcomesovulation, clinical pregnancy, and live birthreported inconsistently and often as secondary or exploratory measures
Moreover, this treatment also improves glucose tolerance and insulin levels in mice on both types of diets
Its ideal for those looking to reduce food noise, support metabolic efficiency, feel more balanced day to day, and maintain consistency over time
Xerf Face Tightening: a non-surgical treatment that uses radiofrequency energy to tighten skin by boosting collagen
The reduction in injection frequency was led by the individuals, with 24 participants reporting a minimum of 2 weeks between injections